Eventide Asset Management
Boston, MAfiles as EVENTIDE ASSET MANAGEMENT, LLC
$7.5bn in 301 US stocks at the end of 30 June 2026. The top 10 are 23.8% of the money. It changed about 16.9% of the portfolio this quarter.
Value
$7.5bn
Stocks
301
Top 10 share
23.8%
Turnover
16.9%
What changed this quarter
New
Bought for the first time this quarter.
- Avalyn PharmaAVLN0.6% of the fund
- Remitly GlobalRELY0.4% of the fund
- TD SynnexSNX0.4% of the fund
- Oruka TherapeuticsORKA0.3% of the fund
- Spyre TherapeuticsSYRE0.2% of the fund
- Black HillsBKH0.2% of the fund
- NXP SemiconductorsNXPI0.2% of the fund
- Achieve Life SciencesACHV0.2% of the fund
- Kailera TherapeuticsKLRA0.2% of the fund
- Tango TherapeuticsTNGX0.2% of the fund
- ExxonMobil HoldingsXOM0.2% of the fund
- CoreWeaveCRWV0.1% of the fund
- Adlai NortyeANL0.1% of the fund
- Cisco SystemsCSCO0.1% of the fund
- KardiganKARD<0.1% of the fund
- Inhibrx BiosciencesINBX<0.1% of the fund
- Kodiak Gas ServicesKGS<0.1% of the fund
- IDEAYA BiosciencesIDYA<0.1% of the fund
- International Business MachinesIBM<0.1% of the fund
- Advanced Energy IndustriesAEIS<0.1% of the fund
- Applied MaterialsAMAT<0.1% of the fund
- CSXCSX<0.1% of the fund
- Broadridge Financial SolutionsBR<0.1% of the fund
- Shift4 PaymentsFOUR<0.1% of the fund
- Thomson Reuters Corp /canTRI<0.1% of the fund
Added
Bought more of a stock they already held.
- Trane TechnologiesTT2.7% of the fund+2%
- United RentalsURI1.6% of the fund+6%
- iRhythm HoldingsIRTC1.4% of the fund+16%
- Beta BionicsBBNX1.3% of the fund+5%
- nVent ElectricNVT1.2% of the fund+2%
- DatadogDDOG1.2% of the fund+43%
- EntergyETR1.1% of the fund+7%
- Dell TechnologiesDELL1.1% of the fund+91%
- Royalty PharmaRPRX1.0% of the fund+5%
- TeradyneTER1.0% of the fund+16%
- Quanta ServicesPWR0.9% of the fund+4%
- Williams CompaniesWMB0.9% of the fund+8%
- Mettler Toledo InternationalMTD0.9% of the fund+3%
- InsmedINSM0.8% of the fund+7%
- Belite BIOBLTE0.8% of the fund+9%
- NvidiaNVDA0.7% of the fund+6%
- Abivax SAABVX0.7% of the fund+23%
- Eastgroup PropertiesEGP0.7% of the fund+2%
- Applied Industrial TechnologiesAIT0.6% of the fund+19%
- CytokineticsCYTK0.6% of the fund+18%
- SterisSTE0.6% of the fund+3%
- Ferguson EnterprisesFERG0.6% of the fund+2%
- Immix BiopharmaIMMX0.5% of the fund+53%
- Cadence Design SystemsCDNS0.5% of the fund+425%
- Lowe's CompaniesLOW0.5% of the fund+4%
Cut
Sold some of their stake.
- Guardant HealthGH3.9% of the fund-17%
- Lam ResearchLRCX3.9% of the fund-2%
- XometryXMTR2.8% of the fund-27%
- Mirum PharmaceuticalsMIRM2.0% of the fund-11%
- Targa ResourcesTRGP1.8% of the fund-2%
- GE VernovaGEV1.7% of the fund-20%
- Scholar Rock HoldingSRRK1.6% of the fund-4%
- KLAKLAC1.3% of the fund-14%
- Axsome TherapeuticsAXSM1.0% of the fund-39%
- Liberty EnergyLBRT0.8% of the fund-4%
- Kymera TherapeuticsKYMR0.8% of the fund-20%
- Collegium PharmaceuticalCOLL0.7% of the fund-4%
- Revolution MedicinesRVMD0.6% of the fund-13%
- Talen EnergyTLN0.5% of the fund-17%
- Apogee TherapeuticsAPGE0.5% of the fund-53%
- Vertiv HoldingsVRT0.4% of the fund-3%
- Huntington BancsharesHBAN0.4% of the fund-35%
- Waste ConnectionsWCN0.3% of the fund-51%
- Amylyx PharmaceuticalsAMLX0.3% of the fund-12%
- WEC Energy GroupWEC0.3% of the fund-14%
- Sionna TherapeuticsSION0.3% of the fund-26%
- BroadcomAVGO0.3% of the fund-6%
- CelcuityCELC0.3% of the fund-19%
- Sutro BiopharmaSTRO0.3% of the fund-18%
- HeartflowHTFL0.2% of the fund-16%
Sold out
Sold their entire stake.
- PrologisPLD-100%
- Global-E OnlineGLBE-100%
- Centessa Pharmaceuticals-100%
- EQTEQT-100%
- ADC Therapeutics SAADCT-100%
- InvivydIVVD-100%
- Oculis Holding AGOCS-100%
- ExxonMobil HoldingsXOM-100%
- Castle BiosciencesCSTL-100%
- Corvus PharmaceuticalsCRVS-100%
- Helus PharmaHELP-100%
- Evolent HealthEVH-100%
- Edgewise TherapeuticsEWTX-100%
- BridgeBio Oncology TherapeuticsBBOT-100%
- CytomX TherapeuticsCTMX-100%
- American TowerAMT-100%
- JFrogFROG-100%
- Vanguard Index FDSVO-100%
- Gen DigitalGEN-100%
- Vivmark ResidentialVMRK-100%
- Veeva SystemsVEEV-100%
- DocusignDOCU-100%
- Avalonbay CommunitiesAVB-100%
- OktaOKTA-100%
- Procore TechnologiesPCOR-100%
Holdings
- Argenx SEARGX
- Share
- 1.6%
- Value
- $117m
- Shares
- 125,668
Held
- Belite BIOBLTE
- Share
- 0.8%
- Value
- $60m
- Shares
- 390,829
+9%
- Abivax SAABVX
- Share
- 0.7%
- Value
- $53m
- Shares
- 394,957
+23%
- Avalyn PharmaAVLN
- Share
- 0.6%
- Value
- $45m
- Shares
- 1,375,486
New
- Apogee TherapeuticsAPGE
- Share
- 0.5%
- Value
- $35m
- Shares
- 260,000
-53%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Guardant HealthGH | 3.9% | $294m | 1,957,828 | -17% |
| Lam ResearchLRCX | 3.9% | $292m | 673,431 | -2% |
| XometryXMTR | 2.8% | $208m | 2,151,845 | -27% |
| Trane TechnologiesTT | 2.7% | $203m | 415,039 | +2% |
| Mirum PharmaceuticalsMIRM | 2.0% | $146m | 1,248,389 | -11% |
| ASML Holding NVASML | 1.8% | $136m | 68,410 | Held |
| Targa ResourcesTRGP | 1.8% | $132m | 490,719 | -2% |
| Old Dominion Freight LineODFL | 1.7% | $130m | 599,458 | Held |
| GE VernovaGEV | 1.7% | $125m | 106,999 | -20% |
| United RentalsURI | 1.6% | $117m | 103,445 | +6% |
| Argenx SEARGX | 1.6% | $117m | 125,668 | Held |
| Scholar Rock HoldingSRRK | 1.6% | $116m | 2,111,410 | -4% |
| iRhythm HoldingsIRTC | 1.4% | $105m | 880,338 | +16% |
| KLAKLAC | 1.3% | $101m | 339,253 | -14% |
| Beta BionicsBBNX | 1.3% | $98m | 6,253,673 | +5% |
| Lattice SemiconductorLSCC | 1.2% | $93m | 611,272 | Held |
| nVent ElectricNVT | 1.2% | $91m | 536,108 | +2% |
| Generac HoldingsGNRC | 1.2% | $90m | 306,850 | Held |
| DatadogDDOG | 1.2% | $89m | 342,324 | +43% |
| Palo Alto NetworksPANW | 1.1% | $86m | 251,535 | Held |
| EntergyETR | 1.1% | $84m | 728,019 | +7% |
| VaxcytePCVX | 1.1% | $80m | 1,380,219 | Held |
| Monolithic Power SystemsMPWR | 1.1% | $80m | 57,790 | Held |
| VistraVST | 1.1% | $79m | 499,466 | Held |
| Dell TechnologiesDELL | 1.1% | $79m | 185,502 | +91% |
| Royalty PharmaRPRX | 1.0% | $78m | 1,380,261 | +5% |
| Axsome TherapeuticsAXSM | 1.0% | $78m | 316,820 | -39% |
| TeradyneTER | 1.0% | $71m | 147,984 | +16% |
| Horton D RDHI | 1.0% | $71m | 436,562 | Held |
| ToastTOST | 0.9% | $69m | 2,494,706 | Held |
| Quanta ServicesPWR | 0.9% | $67m | 93,231 | +4% |
| Williams CompaniesWMB | 0.9% | $67m | 898,241 | +8% |
| Mettler Toledo InternationalMTD | 0.9% | $67m | 52,116 | +3% |
| InsmedINSM | 0.8% | $62m | 583,665 | +7% |
| RB GlobalRBA | 0.8% | $62m | 528,645 | Held |
| Liberty EnergyLBRT | 0.8% | $61m | 2,314,729 | -4% |
| Belite BIOBLTE | 0.8% | $60m | 390,829 | +9% |
| DT MidstreamDTM | 0.8% | $60m | 407,626 | Held |
| Kymera TherapeuticsKYMR | 0.8% | $58m | 504,210 | -20% |
| NasdaqNDAQ | 0.7% | $56m | 711,213 | Held |
| SitimeSITM | 0.7% | $55m | 74,014 | Held |
| NisourceNI | 0.7% | $55m | 1,158,290 | Held |
| Element SolutionsESI | 0.7% | $55m | 1,149,055 | Held |
| NvidiaNVDA | 0.7% | $54m | 273,735 | +6% |
| Abivax SAABVX | 0.7% | $53m | 394,957 | +23% |
| Vulcan MaterialsVMC | 0.7% | $50m | 169,825 | Held |
| O'Reilly AutomotiveORLY | 0.7% | $50m | 544,082 | Held |
| Trevi TherapeuticsTRVI | 0.7% | $50m | 2,660,000 | Held |
| Collegium PharmaceuticalCOLL | 0.7% | $49m | 1,361,228 | -4% |
| Eastgroup PropertiesEGP | 0.7% | $49m | 241,049 | +2% |
| Applied Industrial TechnologiesAIT | 0.6% | $49m | 143,966 | +19% |
| MBX BiosciencesMBX | 0.6% | $48m | 873,492 | Held |
| CytokineticsCYTK | 0.6% | $48m | 564,398 | +18% |
| Ionis PharmaceuticalsIONS | 0.6% | $46m | 575,000 | Held |
| Avalyn PharmaAVLN | 0.6% | $45m | 1,375,486 | New |
| Revolution MedicinesRVMD | 0.6% | $43m | 227,845 | -13% |
| SterisSTE | 0.6% | $42m | 199,560 | +3% |
| Bloom EnergyBE | 0.6% | $42m | 138,192 | Held |
| Ferguson EnterprisesFERG | 0.6% | $41m | 173,453 | +2% |
| Immix BiopharmaIMMX | 0.5% | $40m | 3,891,019 | +53% |
| Cadence Design SystemsCDNS | 0.5% | $39m | 104,219 | +425% |
| Lowe's CompaniesLOW | 0.5% | $39m | 176,976 | +4% |
| Axon EnterpriseAXON | 0.5% | $39m | 69,514 | Held |
| MongoDBMDB | 0.5% | $39m | 114,962 | +84% |
| Celldex TherapeuticsCLDX | 0.5% | $39m | 1,037,000 | Held |
| FastenalFAST | 0.5% | $39m | 804,046 | Held |
| FrontdoorFTDR | 0.5% | $38m | 486,594 | Held |
| Talen EnergyTLN | 0.5% | $38m | 97,373 | -17% |
| Kestra Medical TechnologiesKMTS | 0.5% | $37m | 1,446,742 | Held |
| TransMedics GroupTMDX | 0.5% | $36m | 548,874 | Held |
| Palvella TherapeuticsPVLA | 0.5% | $35m | 231,484 | Held |
| Apogee TherapeuticsAPGE | 0.5% | $35m | 260,000 | -53% |
| Comfort Systems USAFIX | 0.5% | $34m | 17,370 | +97% |
| DexcomDXCM | 0.4% | $34m | 498,202 | Held |
| Definium TherapeuticsDFTX | 0.4% | $33m | 710,000 | +3% |
| BridgeBio PharmaBBIO | 0.4% | $33m | 437,130 | Held |
| RollinsROL | 0.4% | $32m | 767,984 | Held |
| Houlihan LokeyHLI | 0.4% | $32m | 239,140 | Held |
| Ovid TherapeuticsOVID | 0.4% | $32m | 11,812,241 | +19% |
| Nurix TherapeuticsNRIX | 0.4% | $31m | 1,297,893 | Held |
| Vertiv HoldingsVRT | 0.4% | $31m | 92,404 | -3% |
| CoherentCOHR | 0.4% | $31m | 77,487 | +109% |
| Fifth Third BancorpFITB | 0.4% | $30m | 539,040 | +1266% |
| Arrowhead PharmaceuticalsARWR | 0.4% | $30m | 370,000 | Held |
| Remitly GlobalRELY | 0.4% | $30m | 1,332,003 | New |
| MsciMSCI | 0.4% | $29m | 52,607 | +3% |
| Huntington BancsharesHBAN | 0.4% | $29m | 1,641,712 | -35% |
| Disc MedicineIRON | 0.4% | $29m | 395,651 | Held |
| UL SolutionsULS | 0.4% | $29m | 281,062 | +5% |
| Rockwell AutomationROK | 0.4% | $28m | 56,458 | Held |
| ChewyCHWY | 0.4% | $28m | 1,413,874 | Held |
| TD SynnexSNX | 0.4% | $27m | 100,983 | New |
| CG OncologyCGON | 0.4% | $26m | 369,839 | Held |
| Baker HughesBKR | 0.3% | $26m | 459,110 | +5% |
| Waste ConnectionsWCN | 0.3% | $25m | 152,351 | -51% |
| Intuitive SurgicalISRG | 0.3% | $24m | 60,634 | Held |
| Sherwin-WilliamsSHW | 0.3% | $24m | 70,111 | Held |
| Amylyx PharmaceuticalsAMLX | 0.3% | $24m | 1,327,536 | -12% |
| IdexIEX | 0.3% | $23m | 103,503 | +3% |
| Oruka TherapeuticsORKA | 0.3% | $23m | 240,000 | New |
Showing the largest 100 of 301.
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 31.1% since 30 June 2025.
Where the money is
Health care33.2%
Technology22.9%
Industrials19.7%
Energy5.4%
Utilities5.1%
Financial services4.3%
Retail & consumer3.3%
Materials2.4%
Real estate0.7%
Everyday goods0.0%
Media & telecom0.0%
Other3.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.